Sen Bernie Sanders (I-Vt.).Anna Moneymaker/Getty ImagesSen. Bernie Sanders said the price of Ozempic is "outrageously high." He wants to meet with Novo Nordisk's CEO, Bloomberg reports.A recent study found that Ozempic can be made for less than $5 per month — but it costs nearly $1,000.Sen. Bernie Sanders is outraged by the price of Ozempic — so much that he wants to meet with the CEO of its maker, pharma giant Novo Nordisk, Bloomberg reports.Sanders, who is considering hearings on the issue, wants to first talk to Novo chief Lars Fruergaard Jørgensen about cutting the list prices of GLP-1 drugs Ozempic and Wegovy, according to Bloomberg.Sanders — who chairs the Senate Health, Education, Labor, and Pensions (HELP) Committee — was responding to a new study by the medical journal JAMA Network published Wednesday, which found that Ozempic "can likely be manufactured for prices far below current prices, enabling wider access.""A new Yale study found that Ozempic costs less than $5 a month to manufacture," Sanders said in a statement.